Medicare Part D stand-alone prescription drug plans serve a majority of rural Medicare beneficiaries, with premium stabilization efforts influencing plan availability and affordability in 2025 and beyond.
UnitedHealth Group lowers its 2025 revenue forecast due to increased Medicare Advantage plan usage, signaling shifts in health insurance market trends and consumer preferences.
U.S. cancer death rates declined steadily from 2001 to 2022, including during the pandemic, driven by advances in detection and treatment. Regulatory fraud enforcement and new FDA approvals impact healthcare and insurance sectors.
Federal budget proposals to cut Medicare and Medicaid funding risk destabilizing rural healthcare systems in Northern California, impacting access and economic stability.
Pennsylvania House unanimously approves bill to extend moratorium protecting seniors' eligibility for PACE and PACENET prescription drug programs through 2027.
Analysis of the Center for Medicare & Medicaid Innovation's costly projects and their impact on Medicare and Medicaid financial efficiency.
CMS finalizes key aspects of the 2026 Medicare Advantage and Part D programs rule, including expanded insulin coverage, payment plans, and new pharmacy requirements for network participation.
Explore how dance enhances physical fitness, mental health, and social connections in older adults, backed by recent research and health guidelines.
Elevance Health lowers full-year profit forecast despite Q1 revenue growth driven by higher premiums and membership gains in Medicare Advantage and ACA.
Reveleer acquires Novillus to enhance its AI-driven value-based care platform, improving payer-provider collaboration, care gap closure, and clinical intelligence for health plans.
